175 related articles for article (PubMed ID: 11587482)
21. Involvement of Mrp2/MRP2 in the species different excretion route of benzylpenicillin between rat and human.
Choi MK; Kim H; Han YH; Song IS; Shim CK
Xenobiotica; 2009 Feb; 39(2):171-81. PubMed ID: 19255943
[TBL] [Abstract][Full Text] [Related]
22. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene.
Hirouchi M; Suzuki H; Sugiyama Y
Pharm Res; 2005 Apr; 22(4):661-6. PubMed ID: 15846474
[TBL] [Abstract][Full Text] [Related]
23. Ethacrynic-acid-induced glutathione depletion and oxidative stress in normal and Mrp2-deficient rat liver.
Ji B; Ito K; Sekine S; Tajima A; Horie T
Free Radic Biol Med; 2004 Dec; 37(11):1718-29. PubMed ID: 15528031
[TBL] [Abstract][Full Text] [Related]
24. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
Akao T; Sato K; Hanada M
Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
[TBL] [Abstract][Full Text] [Related]
25. Temocaprilat, a novel angiotensin-converting enzyme inhibitor, is excreted in bile via an ATP-dependent active transporter (cMOAT) that is deficient in Eisai hyperbilirubinemic mutant rats (EHBR).
Ishizuka H; Konno K; Naganuma H; Sasahara K; Kawahara Y; Niinuma K; Suzuki H; Sugiyama Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1304-11. PubMed ID: 9067317
[TBL] [Abstract][Full Text] [Related]
26. Functional integrity of hepatocyte canalicular membrane transport of taurocholate and bilirubin diglucuronide in Eisai hyperbilirubinuria rats.
Adachi Y; Kobayashi H; Shouji M; Kitano M; Okuyama Y; Yamamoto T
Life Sci; 1993; 52(9):777-84. PubMed ID: 8437507
[TBL] [Abstract][Full Text] [Related]
27. Role of rat multidrug resistance protein 2 in plasma and biliary disposition of dibromosulfophthalein after microsomal enzyme induction.
Johnson DR; Klaassen CD
Toxicol Appl Pharmacol; 2002 Apr; 180(1):56-63. PubMed ID: 11922777
[TBL] [Abstract][Full Text] [Related]
28. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
[TBL] [Abstract][Full Text] [Related]
29. Expression of MRP2 and MRP3 during liver regeneration after 90% partial hepatectomy in rats.
Chang TH; Hakamada K; Toyoki Y; Tsuchida S; Sasaki M
Transplantation; 2004 Jan; 77(1):22-7. PubMed ID: 14724430
[TBL] [Abstract][Full Text] [Related]
30. Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction.
Nishiya T; Kataoka H; Mori K; Goto M; Sugawara T; Furuhama K
Toxicol Sci; 2006 Jun; 91(2):651-9. PubMed ID: 16543292
[TBL] [Abstract][Full Text] [Related]
31. Characterization of inducible nature of MRP3 in rat liver.
Ogawa K; Suzuki H; Hirohashi T; Ishikawa T; Meier PJ; Hirose K; Akizawa T; Yoshioka M; Sugiyama Y
Am J Physiol Gastrointest Liver Physiol; 2000 Mar; 278(3):G438-46. PubMed ID: 10712264
[TBL] [Abstract][Full Text] [Related]
32. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA.
Saito S; Obata A; Kashiwagi Y; Abe K; Murase K
Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
Moriwaki T; Yasui H; Yamamoto A
Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
[TBL] [Abstract][Full Text] [Related]
34. Identification of the transporters involved in the hepatobiliary transport and intestinal efflux of methyl 1-(3,4-dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) glucuronide, a pharmacologically active metabolite of S-8921.
Sakamoto S; Kusuhara H; Horie K; Takahashi K; Baba T; Ishizaki J; Sugiyama Y
Drug Metab Dispos; 2008 Aug; 36(8):1553-61. PubMed ID: 18474677
[TBL] [Abstract][Full Text] [Related]
35. Involvement of an organic anion transporter (canalicular multispecific organic anion transporter/multidrug resistance-associated protein 2) in gastrointestinal secretion of glutathione conjugates in rats.
Gotoh Y; Suzuki H; Kinoshita S; Hirohashi T; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 2000 Jan; 292(1):433-9. PubMed ID: 10604980
[TBL] [Abstract][Full Text] [Related]
36. Hepatic pharmacokinetics of taurocholate in the normal and cholestatic rat liver.
Hung DY; Siebert GA; Chang P; Roberts MS
Br J Pharmacol; 2005 May; 145(1):57-65. PubMed ID: 15711588
[TBL] [Abstract][Full Text] [Related]
37. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
[TBL] [Abstract][Full Text] [Related]
38. Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
Sugie M; Asakura E; Zhao YL; Torita S; Nadai M; Baba K; Kitaichi K; Takagi K; Takagi K; Hasegawa T
Antimicrob Agents Chemother; 2004 Mar; 48(3):809-14. PubMed ID: 14982769
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of canalicular and sinusoidal taurocholate efflux by cholestatic drugs in human hepatoma HepaRG cells.
Le Vée M; Moreau A; Jouan E; Denizot C; Parmentier Y; Fardel O
Biopharm Drug Dispos; 2022 Dec; 43(6):265-271. PubMed ID: 36195987
[TBL] [Abstract][Full Text] [Related]
40. Induction of multidrug resistance protein 3 in rat liver is associated with altered vectorial excretion of acetaminophen metabolites.
Slitt AL; Cherrington NJ; Maher JM; Klaassen CD
Drug Metab Dispos; 2003 Sep; 31(9):1176-86. PubMed ID: 12920174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
